Ser303
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.7.9
Powered by Cell Signaling Technology
Home > Phosphorylation Site Page: > Ser303  -  NGFR (human)

Site Information
PEGEKLHsDsGIsVD   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 10432300

In vivo Characterization
Methods used to characterize site in vivo:
immunoprecipitation ( 1 ) , mass spectrometry ( 1 ) , mutation of modification site ( 1 )
Disease tissue studied:
brain cancer ( 1 ) , glioblastoma ( 1 ) , glioma ( 1 )
Relevant cell line - cell type - tissue:
brain ( 1 ) , U87MG (glial) ( 1 )

Upstream Regulation
Putative in vivo kinases:
PKACB (human) ( 2 )
Kinases, in vitro:
PKACB (human) ( 2 )
Treatments:
KT5720 ( 1 )

Downstream Regulation
Effects of modification on NGFR:
intracellular localization ( 2 ) , molecular association, regulation ( 1 )
Effects of modification on biological processes:
carcinogenesis, induced ( 1 ) , cell growth, altered ( 2 ) , cytoskeletal reorganization ( 2 )
Induce interaction with:
CLIM1 (human) ( 1 )

References 

1

Ahn BY, et al. (2016) Glioma invasion mediated by the p75 neurotrophin receptor (p75(NTR)/CD271) requires regulated interaction with PDLIM1. Oncogene 35, 1411-22
26119933   Curated Info

2

Higuchi H, Yamashita T, Yoshikawa H, Tohyama M (2003) PKA phosphorylates the p75 receptor and regulates its localization to lipid rafts. EMBO J 22, 1790-800
12682012   Curated Info